Tanaka Noritaka 田中伯享

… Alternative Names

田中伯享タナカノリタカ

Less

Researcher Number	30815882
Other IDs
Affiliation (Current)	2025: 愛知県がんセンター(研究所), がん標的治療TR分野, 研究員 2025: 公益財団法人がん研究会, がん化学療法センター分子薬理部, 客員研究員
Affiliation (based on the past Project Information) *help	2024: 愛知県がんセンター(研究所), がん標的治療TR分野, 研究員 2023: 関西医科大学, 医学部, 助教 2022: 公益財団法人がん研究会, がん化学療法センター分子薬理部, 研究員 2018 – 2019: 公益財団法人がん研究会, がん化学療法センター分子薬理部, 研究員
Review Section/Research Field	Principal Investigator Basic Section 50010:Tumor biology-related Except Principal Investigator Basic Section 59040:Nutrition science and health science-related / Basic Section 50020:Tumor diagnostics and therapeutics-related / Drug development chemistry
Keywords	Principal Investigator 低酸素 / 薬剤耐性 / HIF-1A / KRAS Except Principal Investigator アンメットニーズ / 機能ゲノミクス / がん / 細胞老化 / 抗がん剤感受性 / ケミカルゲノミクス … More / 抗がん剤 / 次世代シーケンス / 希少がん / 薬剤感受性 / 染色体転座 / 遺伝子依存性 / アポトーシス / PI3K / 患者由来細胞 / 分子標的薬 / 肉腫 / 遺伝子異常 / インフォマティクス / 薬剤反応性 / 合成致死 / 脆弱性 / がん依存性マップ / 分子標的 / ケミカルバイオロジー / 新規標的分子 / データベース / 分子標的治療薬 / がん脆弱性遺伝子 / ケミカルジェネティクス Less

がん治療薬誘導性間質細胞老化の分子病態の解明と治療応用
- Principal Investigator
  
  坂本毅治
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 59040:Nutrition science and health science-related
- Research Institution
  Kansai Medical University
KRAS阻害剤による低酸素応答のリプログラミングに関する解析Principal Investigator
- Principal Investigator
  
  田中伯享
- Project Period (FY)
  2023 – 2024
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 50010:Tumor biology-related
- Research Institution
  Kansai Medical University
Elucidation of gene dependence of sarcoma cells using functional genomics approach
- Principal Investigator
  
  DAN Shingo
- Project Period (FY)
  2019 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Japanese Foundation for Cancer Research
Screening of molecular target for cancer therapy by using chemical genetics and functional genomics
- Principal Investigator
  
  DAN shingo
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Drug development chemistry
- Research Institution
  Japanese Foundation for Cancer Research

All 2023 2019 2018 2017

All Journal Article Presentation

[Journal Article] MT1-MMP as a Key Regulator of Metastasis2023
- Author(s)
  Tanaka Noritaka、Sakamoto Takeharu
- Journal Title
  
  Cells
  
  Volume: 12 Issue: 17 Pages: 2187-2187
- DOI
  10.3390/cells12172187
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K19464, KAKENHI-PROJECT-23K28008
[Journal Article] 特集がん遺伝子の発見は現代医療を進歩させたか Ⅰ.がん遺伝子研究の新しい展開 RAS遺伝子を中心としたがん治療戦略の確立2023
- Author(s)
  田中伯享、坂本毅治
- Journal Title
  
  生体の科学
  
  Volume: 74 Issue: 4 Pages: 289-294
- DOI
  10.11477/mf.2425201695
- ISSN
  0370-9531, 1883-5503
- Year and Date
  2023-08-15
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K19464, KAKENHI-PROJECT-23K28008
[Journal Article] Mint3-depletion-induced energy stress sensitizes triple-negative breast cancer to chemotherapy via HSF1 inactivation2023
- Author(s)
  Tanaka Noritaka、Okada Hikari、Yamaguchi Kiyoshi、Seki Masahide、Matsubara Daisuke、Gotoh Noriko、Suzuki Yutaka、Furukawa Yoichi、Yamashita Taro、Inoue Jun-ichiro、Kaneko Shuichi、Sakamoto Takeharu
- Journal Title
  
  Cell Death & Disease
  
  Volume: 14 Issue: 12 Pages: 815-815
- DOI
  10.1038/s41419-023-06352-4
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K19464, KAKENHI-PROJECT-23K18237, KAKENHI-PROJECT-21H02761, KAKENHI-PROJECT-23K28008
[Journal Article] Role of oxygen-sensing mechanism modulator, Mint3, in macrophage-related infl ammation and cancer2023
- Author(s)
  坂本毅治、田中伯享、植松崇之
- Journal Title
  
  Cytometry Research
  
  Volume: 32 Issue: 2 Pages: 1-9
- DOI
  10.18947/cytometryresearch.32.2_1
- ISSN
  0916-6920, 2424-0664
- Year and Date
  2023-04-17
- Language
  Japanese
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K19464, KAKENHI-PROJECT-23K28008
[Journal Article] Antitumor profile of the PI3K inhibitor ZSTK474 in human sarcoma cell lines.2018
- Author(s)
  Namatame N, Tamaki N, Yoshizawa Y, Okamura M, Nishimura Y, Yamazaki K, Tanaka M, Nakamura T, Semba K, Yamori T, Yaguchi SI, Dan S.
- Journal Title
  
  Oncotarget.
  
  Volume: 9(80) Issue: 80 Pages: 35141-35161
- DOI
  10.18632/oncotarget.26216
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16H05105
[Presentation] KRAS阻害剤に対する耐性化とEMTに関する解析2023
- Author(s)
  田中伯享、坂本毅治
- Organizer
  第32回日本がん転移学会学術集会・総会
- Data Source
  KAKENHI-PROJECT-23K28008
[Presentation] The potential effect of KRAS inhibitors on tumor microenvironments2023
- Author(s)
  Noritaka Tanaka, Takeharu Sakamoto
- Organizer
  AACR-NCI-EORTC INTERNATIONAL CONFERENCE ON MOLECULAR TARGETS AND CANCER THERAPEUTICS 2023
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K28008
[Presentation] KRAS阻害剤によるHIF-1Aの発現制御機構2023
- Author(s)
  田中伯享, 坂本毅治
- Organizer
  第46回分子生物学会年会
- Data Source
  KAKENHI-PROJECT-23K28008
[Presentation] The potential effects of KRAS inhibitors on tumor microenvironments2023
- Author(s)
  Noritaka Tanaka、Takeharu Sakamoto
- Organizer
  AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K14576
[Presentation] KRAS阻害剤によるHIF-1α発現制御メカニズム2023
- Author(s)
  田中伯享、坂本毅治
- Organizer
  第27回日本がん分子標的治療学会学術集会
- Data Source
  KAKENHI-PROJECT-23K28008
[Presentation] KRAS阻害剤によるHIF-1α発現制御メカニズム2023
- Author(s)
  田中伯享、坂本毅治
- Organizer
  第23回日本がん分子標的治療学会学術集会
- Data Source
  KAKENHI-PROJECT-23K14576
[Presentation] KRAS阻害剤によるHIF-1A発現制御機構2023
- Author(s)
  田中伯享、坂本毅治
- Organizer
  第46回日本分子生物学会年会
- Data Source
  KAKENHI-PROJECT-23K14576
[Presentation] ゲフィチニブ感受性を起点としたErbB4依存性肺がん細胞株及びその増殖阻害薬の同定2019
- Author(s)
  田中伯享、山崎佳波、宇野佑子、大橋愛美、西村由美子、澤匡明、旦慎吾
- Organizer
  2018年度新学術領域研究学術研究支援基盤形成【先端モデル動物支援プラットフォーム】成果発表会
- Data Source
  KAKENHI-PROJECT-16H05105
[Presentation] Identification of ERBB4 as an actionable target by using selective anticancer effect of EGFR family tyrosine kinase inhibitors2019
- Author(s)
  田中伯享、山崎佳波、宇野佑子、大橋愛美、西村由美子、澤匡明、旦慎吾
- Organizer
  第11回（2019年）日米がん合同会議
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16H05105
[Presentation] ErbB4に依存した増殖を示す肺がん細胞株とその治療薬の同定2018
- Author(s)
  田中伯享、大橋愛美、旦慎吾
- Organizer
  第22回日本がん分子標的治療学会学術集会
- Data Source
  KAKENHI-PROJECT-16H05105
[Presentation] 抗白血病薬クラドリビンの上皮がん細胞に対する抗がん効果2018
- Author(s)
  佐久間貴大、岩澤卓弥、田中伯享、赤塚明宣、山崎佳波、長原礼宗、旦慎吾
- Organizer
  第77回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-16H05105
[Presentation] HER4依存性細胞株におけるHERファミリーチロシンキナーゼ阻害剤の抗がん効果2018
- Author(s)
  田中伯享、山崎佳波、大橋愛美、西村由美子、旦慎吾
- Organizer
  第77回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-16H05105
[Presentation] 大腸がん細胞株のタンキラーゼ阻害剤感受性を予測するAPC変異2017
- Author(s)
  田中伯享、馬島哲夫、旦慎吾、杉本芳一、清宮啓之
- Organizer
  第21回　日本がん分子標的治療学会
- Data Source
  KAKENHI-PROJECT-16H05105

1. DAN shingo (70332202)

# of Collaborated Projects: 2 results

# of Collaborated Products: 7 results
2. 大橋愛美 (50727427)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
3. 赤塚明宣 (30649364)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
4. 礒山翔 (10843394)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. 近藤格 (30284061)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. 坂本毅治 (70511418)

# of Collaborated Projects: 1 results

# of Collaborated Products: 6 results
7. 城村由和 (40616322)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. MATSUURA masaaki

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. USHIJIMA masaru

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

Tanaka Noritaka 田中 伯享

田中 伯享 タナカ ノリタカ

Research Projects

Research Products

Co-Researchers

がん治療薬誘導性間質細胞老化の分子病態の解明と治療応用

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

KRAS阻害剤による低酸素応答のリプログラミングに関する解析Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Elucidation of gene dependence of sarcoma cells using functional genomics approach

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Screening of molecular target for cancer therapy by using chemical genetics and functional genomics

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] MT1-MMP as a Key Regulator of Metastasis2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] 特集 がん遺伝子の発見は現代医療を進歩させたか Ⅰ.がん遺伝子研究の新しい展開 RAS遺伝子を中心としたがん治療戦略の確立2023

Author(s)

Journal Title

DOI

ISSN

Year and Date

Data Source

[Journal Article] Mint3-depletion-induced energy stress sensitizes triple-negative breast cancer to chemotherapy via HSF1 inactivation2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Role of oxygen-sensing mechanism modulator, Mint3, in macrophage-related infl ammation and cancer2023

Author(s)

Journal Title

DOI

ISSN

Year and Date

Language

Data Source

[Journal Article] Antitumor profile of the PI3K inhibitor ZSTK474 in human sarcoma cell lines.2018

Author(s)

Journal Title

DOI

Data Source

[Presentation] KRAS阻害剤に対する耐性化とEMTに関する解析2023

Author(s)

Organizer

Data Source

[Presentation] The potential effect of KRAS inhibitors on tumor microenvironments2023

Author(s)

Organizer

Data Source

[Presentation] KRAS阻害剤によるHIF-1Aの発現制御機構2023

Author(s)

Organizer

Data Source

[Presentation] The potential effects of KRAS inhibitors on tumor microenvironments2023

Author(s)

Organizer

Data Source

[Presentation] KRAS阻害剤によるHIF-1α発現制御メカニズム2023

Author(s)

Organizer

Data Source

[Presentation] KRAS阻害剤によるHIF-1α発現制御メカニズム2023

Tanaka Noritaka 田中伯享

田中伯享タナカノリタカ

[Journal Article] 特集がん遺伝子の発見は現代医療を進歩させたか Ⅰ.がん遺伝子研究の新しい展開 RAS遺伝子を中心としたがん治療戦略の確立2023